BR112023018403A2 - Composições e métodos para tratar policitemia - Google Patents
Composições e métodos para tratar policitemiaInfo
- Publication number
- BR112023018403A2 BR112023018403A2 BR112023018403A BR112023018403A BR112023018403A2 BR 112023018403 A2 BR112023018403 A2 BR 112023018403A2 BR 112023018403 A BR112023018403 A BR 112023018403A BR 112023018403 A BR112023018403 A BR 112023018403A BR 112023018403 A2 BR112023018403 A2 BR 112023018403A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- compositions
- polycythemia
- treat
- treat polycythemia
- Prior art date
Links
- 208000008601 Polycythemia Diseases 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 102000010726 Glycine Plasma Membrane Transport Proteins Human genes 0.000 abstract 1
- 108010063380 Glycine Plasma Membrane Transport Proteins Proteins 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163160412P | 2021-03-12 | 2021-03-12 | |
| US202163185464P | 2021-05-07 | 2021-05-07 | |
| PCT/US2022/020038 WO2022192730A1 (en) | 2021-03-12 | 2022-03-11 | Compositions and methods for treating polycythemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023018403A2 true BR112023018403A2 (pt) | 2023-10-10 |
Family
ID=83228388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023018403A BR112023018403A2 (pt) | 2021-03-12 | 2022-03-11 | Composições e métodos para tratar policitemia |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20260027107A1 (https=) |
| EP (1) | EP4304596A4 (https=) |
| JP (1) | JP2024509265A (https=) |
| KR (1) | KR20230169981A (https=) |
| AU (1) | AU2022233178A1 (https=) |
| BR (1) | BR112023018403A2 (https=) |
| CA (1) | CA3213395A1 (https=) |
| IL (1) | IL305806A (https=) |
| MX (1) | MX2023010449A (https=) |
| WO (1) | WO2022192730A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230169981A (ko) * | 2021-03-12 | 2023-12-18 | 디스크 메디슨, 인크. | 적혈구증가증을 치료하기 위한 조성물 및 방법 |
| CN116942668A (zh) * | 2023-03-17 | 2023-10-27 | 天津医科大学 | Glyt1抑制剂在治疗器官纤维化中的应用 |
| AU2024339974A1 (en) * | 2023-09-15 | 2026-03-26 | Disc Medicine, Inc. | Glyt-1 inhibitors and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20180036A1 (ar) * | 2017-04-18 | 2019-01-30 | Vifor Int Ag | أملاح لمثبطات فروبورتين جديدة |
| KR20230169981A (ko) * | 2021-03-12 | 2023-12-18 | 디스크 메디슨, 인크. | 적혈구증가증을 치료하기 위한 조성물 및 방법 |
-
2022
- 2022-03-11 KR KR1020237034671A patent/KR20230169981A/ko active Pending
- 2022-03-11 MX MX2023010449A patent/MX2023010449A/es unknown
- 2022-03-11 BR BR112023018403A patent/BR112023018403A2/pt unknown
- 2022-03-11 WO PCT/US2022/020038 patent/WO2022192730A1/en not_active Ceased
- 2022-03-11 AU AU2022233178A patent/AU2022233178A1/en active Pending
- 2022-03-11 US US18/280,837 patent/US20260027107A1/en active Pending
- 2022-03-11 EP EP22768132.7A patent/EP4304596A4/en active Pending
- 2022-03-11 IL IL305806A patent/IL305806A/en unknown
- 2022-03-11 JP JP2023555275A patent/JP2024509265A/ja active Pending
- 2022-03-11 CA CA3213395A patent/CA3213395A1/en active Pending
-
2024
- 2024-03-05 US US18/596,341 patent/US20240269132A1/en not_active Abandoned
- 2024-10-23 US US18/923,904 patent/US20250248995A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240269132A1 (en) | 2024-08-15 |
| US20260027107A1 (en) | 2026-01-29 |
| US20250248995A1 (en) | 2025-08-07 |
| MX2023010449A (es) | 2023-11-09 |
| WO2022192730A1 (en) | 2022-09-15 |
| KR20230169981A (ko) | 2023-12-18 |
| JP2024509265A (ja) | 2024-02-29 |
| EP4304596A1 (en) | 2024-01-17 |
| CA3213395A1 (en) | 2022-09-15 |
| IL305806A (en) | 2023-11-01 |
| AU2022233178A1 (en) | 2023-10-26 |
| EP4304596A4 (en) | 2025-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022017393A2 (pt) | Composto, composição farmacêutica, método para tratar um transtorno mediado por brd9, e, uso de um composto | |
| BR112023018403A2 (pt) | Composições e métodos para tratar policitemia | |
| BR112021023359A2 (pt) | Inibidores de g12c de kras e usos dos mesmos | |
| BR112021020285A2 (pt) | Métodos e composições para degradação de proteína alvejada | |
| CL2022000603A1 (es) | Inhibidores prmt5 cooperativos de mta | |
| CY1124652T1 (el) | Παραγωγα 1η-ινδαζολο-3-καρβοξαμιδιου και σχετικες ενωσεις ως αναστολεις παραγοντα d για τη θεραπεια νοσων που χαρακτηριζονται απο μη φυσιολογικη δραστηριοτητα συστηματος συμπληρωματος, οπως π.χ. ανοσολογικες διαταραχες | |
| CY1124206T1 (el) | Αναστολεις πυριδοπυριμδινονης cdk2/4/6 | |
| MX2021009276A (es) | Compuestos de 3-carbonilamino-5-ciclopentil-1h-pirazol que tienen actividad inhibidora sobre cdk2. | |
| BR112021017772A2 (pt) | Bloqueadores de canais de íons carregados e métodos para uso | |
| CY1125784T1 (el) | Υποκατεστημενες δικυκλικες ετεροκυκλικες ενωσεις ως αναστολεις της prmt5 | |
| EA202090530A1 (ru) | Производные 1-бензил-2-имино-4-фенил-5-оксоимидазолидина как ингибиторы протеазы вич | |
| CY1124510T1 (el) | Υποκατεστημενο βενζοφουρανιο, βενζοπυρρολιο, βενζοθειοφαινιο και δομικα σχετικοι αναστολεις του συμπληρωματος | |
| BR112022006018A2 (pt) | Heteroaril-bifenil amidas para o tratamento de doenças relacionadas à pd-l1 | |
| BR112018013251A2 (pt) | compostos heterocílicos tricíclicos fundidos como inibidores da hiv integrase | |
| EA201791955A1 (ru) | ИНГИБИТОРЫ TGF-β | |
| EA201792214A1 (ru) | Соединения замещенного хиназолина | |
| BR112022003408A2 (pt) | Triazolopirimidinas como inibidores de a2a/a2b | |
| BR112021025655A2 (pt) | Inibidores da replicação do vírus da imunodeficiência humana | |
| BR112019024322A2 (pt) | Compostos e composições terapêuticos e métodos de uso dos mesmos | |
| BR112021017809A2 (pt) | Bloqueadores de canais iônicos substituídos por éster e métodos para uso | |
| BR112022003959A2 (pt) | Métodos para tratamento de epilepsia | |
| CO2021001277A2 (es) | Inhibidores de triazol glicolato oxidasa | |
| BR112022012283A2 (pt) | Combinações | |
| BR112022012278A2 (pt) | Combinações | |
| BR112022018067A2 (pt) | Aminas de pirrolopirimidina como inibidores de complemento |